SCHEMBL2167073

SCHEMBL2167073

Cc1c(C)c(O)c2c(c1O)C(=O)c1ccc(Sc3ccccc3)c(Sc3ccccc3)c1C2=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.49
ALDH1A1 P00352 6/20 0.49
MEN1 O00255 5/20 0.49
KMT2A Q03164 5/20 0.49
KDM4E B2RXH2 5/20 0.47
MAPK1 P28482 4/20 0.47
NSD2 O96028 1/20 0.47
ELANE P08246 3/20 0.40
ADORA2A P29274 1/20 0.39
BCL2 P10415 3/20 0.38
MCL1 Q07820 2/20 0.38
RXFP1 Q9HBX9 2/20 0.37
CYP3A4 P08684 3/20 0.36
HPGD P15428 3/20 0.36
ALOX15 P16050 3/20 0.36
MAOA P21397 3/20 0.36
RECQL P46063 3/20 0.36
HSD17B10 Q99714 3/20 0.36
APEX1 P27695 2/20 0.36
ALOX12 P18054 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12402088 0.81 ADORA2A (0.47) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL1038701 0.81 ALDH1A1 (0.66) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL8593971 0.76 MAPT (0.55) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL11141653 0.70 MAPT (0.49) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL496910 0.70 ELANE (0.60) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL22827087 0.68 MAPT (0.86) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL10663800 0.68 MAPT (0.68) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL9296477 0.68 ADORA2A (0.48) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL9297115 0.68 ADORA2A (0.55) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL8583274 0.68 MAPT (0.71) MAPTALDH1A1MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8277695-B2 Reversibly thermochromic compositions BASF SE (DE) 2012-10-02 US disclosed
EP-2032657-B1 REVERSIBLY THERMOCHROMIC COMPOSITIONS BASF SE (DE) 2011-08-10 EP disclosed
US-20110180767-A1 Reversibly thermochromic compositions CIBA CORPORATION 2011-07-28 US disclosed
EP-2032657-A2 REVERSIBLY THERMOCHROMIC COMPOSITIONS Ciba Holding Inc. (CH) 2009-03-11 EP disclosed
WO-2007147847-A2 REVERSIBLY THERMOCHROMIC COMPOSITIONS CIBA HOLDING INC. (CH) 2007-12-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110180767-A1 Reversibly thermochromic compositions C1R, C3AR1, C9 MAPT 55/4885ALDH1A1 2451/4885MEN1 1208/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.